Nucleic acids encoding crispr-associated proteins and uses thereof
AssigneeCureVac AG
InventorsFrédéric CHEVESSIER-TÜNNESEN, Marion POENISCH, Thomas SCHLAKE
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac AG
InventorsFrédéric CHEVESSIER-TÜNNESEN, Marion POENISCH, Thomas SCHLAKE
Estimating the term…
The present invention relates to the field of biomedicine, and in particular to the field of therapeutic nucleic acids. The present invention provides artificial nucleic acids, in particular RNAs, encoding CRISPR-associated proteins. A (pharmaceutical) composition and kit-of-parts comprising the same are also provided. Furthermore, the present invention relates to the artificial nucleic acid, (pharmaceutical) composition, or kit-of-parts for use in medicine, and in particular in the treatment and/or prophylaxis of diseases amenable to treatment with CRISPR-associated proteins.
An RNA molecule comprising:
An mRNA having at least 85% sequence identity to the nucleic acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.